Eva Reznickova

Olomouc, 77146, Czech Republic

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

Attack of NADH and ascorbate toward metal-activated ligand of organoiridium(III) compound.

Attack of NADH and ascorbate toward metal-activated ligand of organoiridium(III) compound.

Journal: Journal of inorganic biochemistry
Published: February 13, 2026

First-in-Class Dual PDGFR/Carbonic Anhydrase IX/XII Inhibitors: 6,7-Dimethoxyquinoline-Sulfonamides as Promising Antileukemic Agents.

First-in-Class Dual PDGFR/Carbonic Anhydrase IX/XII Inhibitors: 6,7-Dimethoxyquinoline-Sulfonamides as Promising Antileukemic Agents.

Journal: Journal of medicinal chemistry
Published: January 26, 2026

Synthesis and antimitotic activity of 2-phenyl-6-pyridinyl-2H-pyrazolo[4,3-c]pyridines.

Synthesis and antimitotic activity of 2-phenyl-6-pyridinyl-2H-pyrazolo[4,3-c]pyridines.

Journal: RSC advances
Published: November 28, 2025

3H-pyrazolo[4,3-f]quinoline hinge binder, a tunable scaffold for development of novel kinase inhibitors against FLT3-driven leukemia.

3H-pyrazolo[4,3-f]quinoline hinge binder, a tunable scaffold for development of novel kinase inhibitors against FLT3-driven leukemia.

Journal: European journal of medicinal chemistry
Published: September 16, 2025

Strategies for the treatment of acute myeloid leukemia with FLT3 mutations: a patent review.

Strategies for the treatment of acute myeloid leukemia with FLT3 mutations: a patent review.

Journal: Expert opinion on therapeutic patents
Published: December 24, 2024

Synthesis and photo-induced anticancer activity of new 2-phenylethenyl-1H-benzo[e]indole dyes.

Synthesis and photo-induced anticancer activity of new 2-phenylethenyl-1H-benzo[e]indole dyes.

Journal: European journal of medicinal chemistry
Published: July 02, 2024

Anticancer dinuclear Ir(III) complex activates Nrf2 and interferes with NAD(H) in cancer cells.

Anticancer dinuclear Ir(III) complex activates Nrf2 and interferes with NAD(H) in cancer cells.

Journal: Journal of inorganic biochemistry
Published: June 27, 2024

Synthesis and photodynamic activity of new 5-[(E)-2-(3-alkoxy-1-phenyl-1H-pyrazol-4-yl)ethenyl]-2-phenyl-3H-indoles.

Synthesis and photodynamic activity of new 5-[(E)-2-(3-alkoxy-1-phenyl-1H-pyrazol-4-yl)ethenyl]-2-phenyl-3H-indoles.

Journal: Archiv der Pharmazie
Published: April 16, 2024

Identification of furo[2,3-d]pyrimidin-4-ylsulfanyl-1,3,4-thiadiazole derivatives as novel FLT3-ITD inhibitors.

Identification of furo[2,3-d]pyrimidin-4-ylsulfanyl-1,3,4-thiadiazole derivatives as novel FLT3-ITD inhibitors.

Journal: European journal of medicinal chemistry
Published: April 03, 2024

Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping.

Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping.

Journal: Journal of medicinal chemistry
Published: August 03, 2023

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma.

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma.

Journal: Frontiers in oncology
Published: June 12, 2023

Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines.

Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines.

Journal: Investigational new drugs
Published: January 26, 2023
Showing 1-12 of 42

Last Updated: 09/26/2026